awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34322552-39D82828-5026-4810-9380-4D153FBCE868
Q34322552-39D82828-5026-4810-9380-4D153FBCE868
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34322552-39D82828-5026-4810-9380-4D153FBCE868
A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North Central Cancer Treatment Group Study N0528
P2860
Q34322552-39D82828-5026-4810-9380-4D153FBCE868
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34322552-39D82828-5026-4810-9380-4D153FBCE868
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7012b9eaf15f43dfb972bd70b84b98be500d1808
P2860
A phase I and pharmacokinetic study of daily oral cediranib, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer: a study of the Nati